PDL BioPharma (Nasdaq: PDLI) is a biopharmaceutical company focused on discovering, developing and commercializing innovative therapies for severe or life-threatening illnesses.
Recent Mentions on Fool.com
- High-Yield Horror: These 3 Stocks Yielding 12% (or Higher) Could Face Huge Dividend Cuts
- 3 Reasons a Company May Choose to Cut Its Dividend
- A Reduced Payout Could Be in the Cards for These High-Yield Dividend Stocks
- The Best Return on Equity in Biotech
- 3 Healthcare Companies Whose Profits Can't Be Trusted